Hôpital Maisonneuve-Rosemont is a hospital in Montreal, Quebec, Canada, located in the boroughs of Rosemont–La Petite-Patrie and Mercier-Hochelaga-Maisonneuve. It serves the eastern part of the city and offers 800 beds. It employs 5,000 people and 3,000 students annually.

There are 800 beds in Hôpital Maisonneuve - Rosemont.

During the past decade, Hôpital Maisonneuve - Rosemont conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 92 clinical trials were completed, i.e. on average, 64.8% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 46 clinical trials were completed. i.e. 112.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Maisonneuve - Rosemont" #1 sponsor was "Maisonneuve-Rosemont Hospital" with 57 trials, followed by "NCIC Clinical Trials Group" with 19 trials sponsored, "Hoffmann-La Roche" with 16 trials sponsored, "Celgene" with 13 trials sponsored and "McMaster University" with 13 trials sponsored. Other sponsors include 216 different institutions and companies that sponsored additional 124 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Maisonneuve - Rosemont" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 20 trials as a collaborator, "NCIC Clinical Trials Group" with 12 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator and "Bayer" with 7 trials as a collaborator. Other collaborators include 241 different institutions and companies that were collaborators in the rest 166 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Maisonneuve - Rosemont" are "Breast Cancer" (24 trials), "Lymphoma" (11 trials), "Multiple Myeloma" (11 trials), "Acute Myeloid Leukemia" (8 trials) and "Ulcerative Colitis" (8 trials). Many other conditions were trialed in "Hôpital Maisonneuve - Rosemont" in a lesser frequency.

Most popular intervention types in "Hôpital Maisonneuve - Rosemont" are "Drug" (221 trials), "Other" (56 trials), "Radiation" (36 trials), "Biological" (34 trials) and "Procedure" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Dexamethasone" (13 trials), "Cyclophosphamide" (12 trials), "placebo" (12 trials) and "radiation therapy" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Maisonneuve - Rosemont" are 287 trials for "All" genders, 38 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Maisonneuve - Rosemont". undefined are not yet recruiting, 33 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 196 completed trials in Hôpital Maisonneuve - Rosemont, undefined suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Maisonneuve - Rosemont, 19 "Phase 1" clinical trials were conducted, 84 "Phase 2" clinical trials and 151 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 49 trials that are defined as “Not Applicable".

Hôpital Maisonneuve - Rosemont has several departments that took part in Clinical trials: "Centre de recherche de l'Institut universitaire de geriatrie de Montreal" - 8 trials, "Recherche Médicale St-Jérôme Inc." - 5 trials, "Hôpital Maisonneuve - Rosemont; Recherche Clinique de Neurologie" - 5 trials, "Groupe de recherche interdisciplinaire sur les maladies neuromusculaires" - 4 trials